Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cardiotoxicity × Atorvastatin × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Overall Survival 1 Inflammatory Breast Neoplasms 1 Heart Diseases 1 Cardiotoxicity 1

Interventions

Doxorubicin 3 Docetaxel 2 Cyclophosphamide 2 Trastuzumab 1 Neoadjuvant Therapy 1 Methotrexate 1 Leucovorin 1 High-Intensity Interval Training 1 Hematologic Tests 1 Filgrastim 1 Exercise 1 Epirubicin 1 Echocardiography 1 Dexrazoxane 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡